MoneyWorks4Me

Norris Medicines informs about closure of trading window

29 Sep 2023 Evaluate

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, Norris Medicines has informed that the trading window of the Company will remain closed from 1st October, 2023 till 48 hours of the declaration of the Unaudited financial statements for the quarter ended 30th September, 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..